ABSTRACT
INTRODUCTION: HbC is a common structural hemoglobinopathy especially in West Africa. Prevalence and regional distribution of HbC in Saudi Arabia are widely undocumented. Patients with homozygous HbC disease may have mild hemolytic anemia whereas combination with hemoglobin S (HbS) leads to a clinically severe phenotype. AIM: The current epidemiological study, considered the largest from Saudi Arabia, aimed to evaluate the regional prevalence of the HbC variant among the couples participating in the premarital screening program from 2011 to 2018. METHODS: Data from the PMSGC program were obtained for premarital screening and genetic counseling. The collected data were then entered into the SEHA platform, a centralized electronic repository for the 13 designated regions in Saudi Arabia. Hemoglobin electrophoresis samples are analyzed using either HPLC, capillary electrophoresis, or a combination of both methods to confirm the presence of abnormal hemoglobin bands. RESULTS: This study included 1,871,184 individuals from 2011 to 2018. Of those, 49.8% were males and 50.2% were females. 112,618 (6.0%) had an abnormal test. Total number of Hb C cases were 778 (0.04%). HbC trait (HbAC) was detected in 764 participants while homozygous HbC (HbCC) and combined heterozygous (HbSC) were found in 9 and 5 cases, respectively. The regions near the Red Sea have higher rates than the central and eastern regions. CONCLUSION: HbC is a rare variant in Saudi Arabia with varying regional frequencies. HbC variant is more common in Mecca and Madina regions. The geographic area of HbC distribution differs from the areas with high prevalence of HbS, which explains why HbSC disease cases are overwhelmingly rare.
Subject(s)
Hemoglobin C Disease , Humans , Saudi Arabia/epidemiology , Male , Female , Prevalence , Adult , Hemoglobin C Disease/epidemiology , Hemoglobin C Disease/genetics , Hemoglobin C Disease/blood , Hemoglobin C/genetics , Middle Aged , Young AdultABSTRACT
The thrombotic risk with haemoglobin C trait (HbAC) or haemoglobin C disease (HbCC) is unclear. However, individuals with HbCC have demonstrated chronic haemolysis, higher blood viscosity and altered rheology when compared to individuals with wild-type haemoglobin (HbAA). These physiological alterations may theoretically translate to increased risk of thrombosis; therefore, a systematic literature review was performed to investigate the possible association between HbAC and/or HbCC and thrombosis. Twenty-two studies met inclusion criteria representing 782 individuals with HbAC (n = 694) or HbCC (n = 88). Fifteen studies described the presence/absence of venous thromboembolism (VTE) in patients with HbAC (n = 685) or HbCC (n = 79), while seven studies described patients with HbAC (n = 9) or HbCC (n = 9) and arterial thrombosis. Most (n = 20) studies were case reports or case series; however, two studies suggested a potential increased VTE risk with HbAC compared to HbAA in (i) all patients (OR 2.2, 95% CI: 0.9-5.5) and in (ii) pregnant individuals (RR 3.7, 95% CI 0.9-16). This review is the largest assessment of patients with HbC trait or disease and thrombosis to date; despite its limitations, the findings suggest HbC may be a predisposing risk factor to thrombosis. Prospective cohort studies are warranted to definitively elucidate the risk of thrombosis in this population.
Subject(s)
Hemoglobin C Disease , Hemoglobinopathies , Thrombosis , Venous Thromboembolism , Pregnancy , Female , Humans , Hemoglobin C , Venous Thromboembolism/epidemiology , Venous Thromboembolism/etiology , Prospective Studies , Thrombosis/etiology , Risk FactorsSubject(s)
Hemoglobin C Disease/diagnosis , Hemoglobin C/analysis , Adult , Black or African American , Anemia/diagnosis , Female , HumansABSTRACT
Abstract Hemoglobin C is the second most frequent Hb variant in Brazil and the world. Hemoglobin C trait is described as a benign and asymptomatic condition. There is little information in the literature about the association of retinal vascular disease and the presence of hemoglobin AC, being this information restricted to a few case reports. This case report describes a 26-year-old female patient with hemoglobin C trait. She presents areas of non-perfusion and arteriovenous shunts in the retinal temporal periphery of the left eye, like changes in Goldberg's stage II of proliferative sickle retinopathy. After three years of follow-up, the patient exhibits the same the alteration in right eye as well.
Resumo A hemoglobina C é a segunda variante de hemoglobina mais comum no Brasil e no mundo. O traço C é descrito como uma condição benigna e assintomática. Há pouca informação na literatura sobre a associação de doença vascular retiniana e a presença de hemoglobina AC, sendo esta informação restrita a alguns poucos relatos de casos. Este relato de caso descreve uma paciente do gênero feminino de 26 anos de idade com traço C. Ela apresenta áreas de não perfusão e shunts artério-venosos na periferia temporal da retina do olho esquerdo, similar ao estágio II de Goldberg de retinopatia proliferativa falciforme. Após três anos de acompanhamento, a paciente apresentou a mesma alteração também em olho direito.
Subject(s)
Humans , Female , Adult , Retinal Diseases/etiology , Hemoglobin C Disease/complications , Retinal Diseases/blood , Hemoglobin C Disease/blood , Anemia, Sickle Cell/complications , Anemia, Sickle Cell/bloodSubject(s)
Acute Chest Syndrome/epidemiology , Anemia, Sickle Cell/epidemiology , Postpartum Period , Pregnancy Complications, Hematologic/epidemiology , Pregnancy Trimester, Third , Puerperal Disorders/epidemiology , Acute Chest Syndrome/etiology , Adult , Anemia, Sickle Cell/complications , Female , Follow-Up Studies , Hemoglobin C Disease/complications , Hemoglobin C Disease/epidemiology , Hospitalization/statistics & numerical data , Humans , Incidence , Pregnancy , Prospective Studies , Sickle Cell Trait/complications , Sickle Cell Trait/epidemiology , Survival Analysis , Venous Thromboembolism/epidemiology , Venous Thromboembolism/etiology , Young AdultSubject(s)
Anemia, Sickle Cell/drug therapy , Anti-Bacterial Agents/therapeutic use , Gastrointestinal Microbiome/drug effects , Rifaximin/therapeutic use , Adult , Analgesics, Opioid/therapeutic use , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/microbiology , Anti-Bacterial Agents/pharmacology , Cellular Senescence , Female , Hemoglobin C Disease/blood , Hemoglobin C Disease/drug therapy , Hemoglobin C Disease/microbiology , Humans , Hydroxyurea/therapeutic use , L-Selectin/analysis , Leukocyte Count , Male , Middle Aged , Neutrophils/chemistry , Pain/drug therapy , Pain/etiology , Quality of Life , Receptors, CXCR4/analysis , Rifaximin/pharmacology , Sickle Cell Trait/blood , Sickle Cell Trait/drug therapy , Sickle Cell Trait/microbiology , Vascular Diseases/etiology , Young Adult , beta-Thalassemia/blood , beta-Thalassemia/drug therapy , beta-Thalassemia/microbiologyABSTRACT
Hereditary spherocytosis (HS) is characterised by increased osmotic fragility and enhanced membrane loss of red blood cells (RBC) due to defective membrane protein complexes. In our diagnostic laboratory, we observed that pyruvate kinase (PK) activity in HS was merely slightly elevated with respect to the amount of reticulocytosis. In order to evaluate whether impaired PK activity is a feature of HS, we retrospectively analysed laboratory data sets from 172 unrelated patients with HS, hereditary elliptocytosis (HE), glucose-6-phosphate dehydrogenase (G6PD) or PK deficiency, sickle cell or haemoglobin C disease, or ß-thalassaemia minor. Results from linear regression analysis provided proof that PK activity decreases with rising reticulocyte counts in HS (R2 = 0·15; slope = 9·09) and, less significantly, in HE (R2 = 0·021; slope = 8·92) when compared with other haemolytic disorders (R2 ≥ 0·65; slopes ≥ 78·6). Reticulocyte-adjusted erythrocyte PK activity levels were significantly lower in HS and even declined with increasing reticulocytes (R2 = 0·48; slope = -9·74). In this report, we describe a novel association between HS and decreased PK activity that is apparently caused by loss of membrane-bound PK due to impaired structural integrity of the RBC membrane and may aggravate severity of haemolysis in HS.
Subject(s)
Erythrocyte Membrane/enzymology , Erythrocytes, Abnormal/enzymology , Pyruvate Kinase/metabolism , Spherocytosis, Hereditary/enzymology , Adolescent , Adult , Aged , Anemia, Hemolytic, Congenital Nonspherocytic/enzymology , Anemia, Hemolytic, Congenital Nonspherocytic/pathology , Anemia, Sickle Cell/enzymology , Anemia, Sickle Cell/pathology , Child , Child, Preschool , Erythrocyte Membrane/pathology , Erythrocytes, Abnormal/pathology , Female , Hemoglobin C Disease/enzymology , Hemoglobin C Disease/pathology , Humans , Infant , Male , Middle Aged , Pyruvate Kinase/deficiency , Pyruvate Metabolism, Inborn Errors/enzymology , Pyruvate Metabolism, Inborn Errors/pathology , Reticulocytes/enzymology , Reticulocytes/pathology , Spherocytosis, Hereditary/pathology , beta-Thalassemia/enzymology , beta-Thalassemia/pathologyABSTRACT
BACKGROUND: Glucose-6-phosphate dehydrogenase deficiency (G6PDd), haemoglobin C (HbC) and S (HbS) are inherited blood disorders (IBD) common in populations in malaria endemic areas. All are associated to some degree with protection against clinical malaria whilst additionally G6PDd is associated with haemolysis following treatment with 8-aminoquinolines. Measuring the prevalence of these inherited blood disorders in affected populations can improve understanding of disease epidemiology. Current methodologies in epidemiological studies commonly rely on individual target amplification and visualization; here a method is presented to simultaneously detect the polymorphisms and that can be expanded to include other single nucleotide polymorphisms (SNPs) of interest. METHODS: Human DNA from whole blood samples was amplified in a novel, multiplex PCR reaction and extended with SNP-specific probes in an allele specific primer extension (ASPE) to simultaneously detect four epidemiologically important human markers including G6PD SNPs (G202A and A376G) and common haemoglobin mutations (HbS and HbC). The products were hybridized to magnetic beads and the median fluorescence intensity (MFI) was read on MAGPIX® (Luminex corp.). Genotyping data was compared to phenotypical data generated by flow cytometry and to established genotyping methods. RESULTS: Seventy-five samples from Burkina Faso (n = 75/78, 96.2%) and 58 samples from The Gambia (n = 58/61, 95.1%) had a G6PD and a HBB genotype successfully assigned by the bead-based assay. Flow cytometry data available for n = 61 samples further supported the concordance between % G6PD normal/deficient cells and genotype. CONCLUSIONS: The bead based assay compares well to alternative measures of genotyping and phenotyping for G6PD. The screening is high throughput, adaptable to inclusion of multiple targets of interest and easily standardized.
Subject(s)
Anemia, Sickle Cell/diagnosis , Genotyping Techniques/methods , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Hemoglobin C Disease/diagnosis , Polymorphism, Single Nucleotide , Adolescent , Adult , Burkina Faso , Child , Glucosephosphate Dehydrogenase/genetics , Hemoglobin C/genetics , Hemoglobin, Sickle/genetics , Humans , Malaria/complications , Male , Middle Aged , Young AdultSubject(s)
Hemoglobin C/genetics , Hemoglobin E/genetics , Hemoglobinopathies/genetics , Asymptomatic Diseases , Chromatography, High Pressure Liquid , Erythrocyte Count , Erythrocyte Indices , Female , Hemoglobin C Disease/blood , Hemoglobin C Disease/genetics , Hemoglobinopathies/blood , Heterozygote , Humans , Infant , Iron/bloodABSTRACT
Sickle cell disease (SCD) is a common, life-threatening genetic disorder that is best managed when diagnosed early by newborn screening. However, SCD is most prevalent in low-resource regions of the world where newborn screening is rare and diagnosis at the point-of-care is challenging. In many such regions, the majority of affected children die, undiagnosed, before the age of 5 years. A rapid and affordable point-of-care test for SCD is needed. The diagnostic accuracy of HemoTypeSC, a point-of-care immunoassay, for SCD was evaluated in individuals who had SCD, hemoglobin C disease, the related carrier (trait) states, or a normal hemoglobin phenotype. Children and adults participated in low-, medium- and high-resource environments (Ghana [n = 383], Martinique [n = 46], and USA [n = 158]). Paired blood specimens were obtained for HemoTypeSC and a reference diagnostic assay. HemoTypeSC testing was performed at the site of blood collection, and the reference test was performed in a laboratory at each site. In 587 participants, across all study sites, HemoTypeSC had an overall sensitivity of 99.5% and specificity of 99.9% across all hemoglobin phenotypes. The test had 100% sensitivity and specificity for sickle cell anemia. Sensitivity and specificity for detection of normal and trait states were >99%. HemoTypeSC is an inexpensive (<$2 per test), accurate, and rapid point-of-care test that can be used in resource-limited regions with a high prevalence of SCD to provide timely diagnosis and support newborn screening programs.
Subject(s)
Anemia, Sickle Cell/diagnosis , Immunoassay , Point-of-Care Systems , Adult , Anemia, Sickle Cell/blood , Anemia, Sickle Cell/epidemiology , Antibodies, Monoclonal/immunology , Child , Developing Countries , Early Diagnosis , Female , Ghana/epidemiology , Hemoglobin A/analysis , Hemoglobin C/analysis , Hemoglobin C Disease/blood , Hemoglobin C Disease/diagnosis , Hemoglobin C Disease/epidemiology , Hemoglobin, Sickle/analysis , Humans , Immunoassay/economics , Infant, Newborn , Male , Martinique/epidemiology , Neonatal Screening/economics , Neonatal Screening/methods , Prevalence , Prospective Studies , Sensitivity and Specificity , Sickle Cell Trait/blood , Sickle Cell Trait/diagnosis , Sickle Cell Trait/epidemiology , Single-Blind MethodSubject(s)
Humans , Female , Adult , Splenectomy , Thalassemia , Thromboembolism , Hemoglobin C DiseaseABSTRACT
A 17-year-old male presented with acute hemolysis with stomatocytosis, elevated mean corpuscular hemoglobin concentration (MCHC), and osmotic gradient ektacytometry consistent with marked erythrocyte dehydration. Erythrocytes from both parents also demonstrated evidence of dehydration with elevated MCHC and abnormal ektacytometry, but neither to the degree of the patient. Genetic studies revealed the patient had hereditary xerocytosis (HX) due to a novel PIEZO1 mutation inherited from his mother and hemoglobin C (HbC) trait inherited from his father. HbC trait accentuated the erythrocyte dehydration of HX. Coinheritance of interrelated disorders and/or modifier alleles should be considered whenever severe erythrocyte dehydration is observed.
Subject(s)
Anemia, Hemolytic, Congenital/complications , Anemia, Hemolytic, Congenital/genetics , Erythrocytes/pathology , Hemoglobin C Disease/complications , Hemoglobin C Disease/genetics , Hydrops Fetalis/genetics , Adolescent , Anemia, Hemolytic, Congenital/blood , Erythrocyte Indices , Hemoglobin C Disease/blood , Humans , Hydrops Fetalis/blood , Ion Channels/genetics , Male , MutationABSTRACT
BACKGROUND: - Hemoglobin C is a hemoglobin variant encountered worldwide. The regionswith high prevalence are West Africa and South-East Asia.The objective of this study is to report cases of hemoglobin C disease brought together during these last twelve years in the Laboratory of Biochemistry and Toxicology of RabatMilitary Hospital Mohammed V (MHIMV). METHODS: - This was a retrospective study including111 cases of hemoglobin C disease collected in the Laboratory of Biochemistry of the MHIMVover the past 12 years. A questionnairewasfulfilledwith the epidemiological data,clinical data and the results of the biological explorations. The screening of the hemoglobin variant in this study included several biochemical (hemoglobin electrophoresis at acid and alkalinepH) and hematological tests. RESULTS: - Sex-ratio was equal to 1,22. The age at the time of diagnosis ranges between 4 and 80years old, with the mean of 38. North-West regions of Morocco seem most affected. The most frequent reasons for prescription of the hemoglobin's studywere: biological abnormalities, splenomegaly and anemic syndrome. Blood smear reveals frequently anisopoikilocytosis and red blood target. The biochemical tests contribute to the diagnosis and reveal various and varied etiological groups: heterozygous A/C (75%),homozygous C/C (8%), double heterozygous S/C (9%),C/ß+-thal (6%) andC/O-Arab (2%). Conclusion - The results of the present descriptive study are in line with the literature data. The importance of genetic counseling and the installation of a national card of systematic neonatal tracking seemto be unavoidable.
Subject(s)
Hemoglobin C Disease/diagnosis , Hemoglobin C Disease/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Blood Protein Electrophoresis , Child , Child, Preschool , Cohort Studies , Female , Genetic Testing , Hematologic Tests , Hemoglobin C/analysis , Hemoglobin C/genetics , Hemoglobin C/metabolism , Hemoglobin C Disease/blood , Hemoglobin C Disease/genetics , Humans , Male , Middle Aged , Morocco/epidemiology , Retrospective Studies , Young AdultABSTRACT
BACKGROUND: Pregnancy represents a challenge for women with sickle cell disease (SCD), with higher rates of both maternal and fetal complications. The aim of this study was to evaluate the impact of prophylactic transfusion support administered specifically to pregnant women with sickle hemoglobin C disease. MATERIALS AND METHODS: Patients were divided into two groups according to the type of transfusion support received: 10 women received prophylactic erythrocytapheresis or manual exchange transfusion at 28 weeks of gestation, and 14 received transfusions only on demand, due to acute complications, or received no transfusions at all. RESULTS: Our results indicated higher frequencies of SCD-related complications in the group that did not receive prophylactic transfusion support (35.7% vs. only 10% in the erythrocytapheresis group). Furthermore, these complications were more severe in this group and included all cases of acute chest syndrome. A significant difference was observed concerning gestational age at birth (38.7 weeks in the transfusion group vs. 34.4 weeks, p = 0.037), with a higher frequency of preterm births in the nontransfused group (69.23% vs. 30% in the transfusion group). CONCLUSION: We demonstrated a clear reduction of unfavorable outcomes in patients receiving prophylactic transfusions, probably reflecting better maternal and fetal conditions, which corroborated to the more satisfactory indices of vitality, observed in newborns. Considering that erythrocytapheresis or manual exchange transfusions both represent feasible and safe procedures, they could represent important tools for the optimal management of these patients.
Subject(s)
Blood Component Removal , Erythrocyte Transfusion , Exchange Transfusion, Whole Blood , Hemoglobin C Disease/therapy , Pregnancy Complications, Hematologic/therapy , Prenatal Care/methods , Adult , Female , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications/prevention & control , Treatment OutcomeABSTRACT
Patients with hemoglobin C disease (CC) usually do not develop severe complications in comparison with individuals with sickle cell anemia (SS) or with sickle cell hemoglobin C disease (SC). The present study compared the hematological, biochemical, hemorheological and clinical characteristics of CC patients to those of SS, SC and healthy individuals (AA). Blood viscosity was measured at 225 s(-1) with a cone plate viscometer. The hematocrit-to-blood viscosity ratio (HVR), i.e. an index of red blood cell (RBC) oxygen transport effectiveness, was calculated. RBC deformability was determined at 30 Pa by ektacytometry, and RBC aggregation properties by syllectometry. CC and SC had higher blood viscosity and lower HVR than AA. Nevertheless, HVR was higher in CC compared to SS and tended to be higher than in SC. The CC group exhibited very rigid hyperchromic RBC compared to the three other groups. RBC aggregation abnormalities were observed in CC: low RBC aggregation index and high RBC aggregates strength. Despite these hemorheological abnormalities, CC never had hospitalized painful vaso-occlusive crisis or acute chest syndrome. In contrast, all of them had splenomegaly. Of note, 2 out of 7 CC developed retinopathy or otologic disorders. Whether the blood hyperviscosity and decreased RBC deformability are responsible for these complications is unknown. The higher oxygen transport effectiveness (i.e., HVR) of CC compared to SS is probably at the origin of the very low risk of medical complication in this population.
Subject(s)
Erythrocytes/metabolism , Hemoglobin C Disease/blood , Hemorheology , Adult , Blood Viscosity , Erythrocyte Count , Erythrocyte Deformability , Female , Hemoglobin C Disease/pathology , Humans , Male , Middle AgedABSTRACT
Sickle cell nephropathy is a common complication in patients with sickle cell hemoglobinopathies. In these disorders, polymerization of mutated hemoglobin S results in deformation of red blood cells, which can cause endothelial cell injury in the kidney that may lead to thrombus formation when severe or manifest by multilayering of the basement membranes (glomerular and/or peritubular capillaries) in milder forms of injury. As the injury progresses, the subsequent ischemia, tubular dysfunction, and glomerular scarring can result in CKD or ESRD. Sickle cell nephropathy can occur in patients with homozygous hemoglobin SS or heterozygous hemoglobin S (hemoglobin SC, hemoglobin S/ß(0)-thalassemia, and hemoglobin S/ß(+)-thalassemia). Clinical manifestations resulting from hemoglobin S polymerization are often milder in patients with heterozygous hemoglobin S. These patients may not present with clinically apparent acute sickle cell crises, but these milder forms can provide a unique view of the kidney injury in sickle cell disease. Here, we report a patient with hemoglobin SC disease who showed peritubular capillary and vasa recta thrombi and capillary basement membrane alterations primarily involving the renal medulla. This patient highlights the vascular occlusion and endothelial cell injury in the medulla that contribute to sickle cell nephropathy.
Subject(s)
Anemia, Sickle Cell/complications , Hemoglobin C Disease/complications , Kidney Diseases/etiology , Kidney Medulla/blood supply , Thrombosis/etiology , Adult , Biopsy , Female , Humans , Kidney Medulla/pathology , Microvessels , Sickle Cell Trait , Thrombosis/pathologyABSTRACT
The aim of this study was the determination of hemoglobin (Hb) variants and ABO blood groups in a school population aged 6 to 9 years in the township of Agbandé-Yaka in North Togo. A cross-sectional study was carried out on 570 children of four primary schools at Agbande-Yaka, between March and July 2010. Hemoglobin characterization was done by alkaline buffer electrophoresis and the blood types ABO-Rhesus (Rh) D by immuno-hematological methods. A Hb variant was detected in 37.0% of the schoolchildren. Among them, the AS trait accounted for 11.9% and the AC trait for 20.2%. Homozygous Hb S (HBB: c.20A>T) was not found but Hb C (HBB: c.19G>A) appeared at a frequency of 3.3%, while compound heterozygotes carrying Hb SC were seen at a frequency of 1.6%. The O, B and A blood groups accounted for 49.0, 26.8 and 21.9%, respectively. The Hb anomalies reached a high prevalence in this school population. These results are remarkable by the absence of homozygous Hb S individuals compared to homozygous Hb C individuals, which were as numerous as expected. The frequencies of the ABO blood groups are similar to what has been found in other West African populations.